《Synthesis and discovery of ω-3 polyunsaturated fatty acid- alkanolamine (PUFA-AA) derivatives as anti-inflammatory agents targeting Nur77》 was written by Fang, Hua; Zhang, Jianyu; Ao, Mingtao; He, Fengming; Chen, Weizhu; Qian, Yuqing; Zhang, Yuxiang; Xu, Yang; Fang, Meijuan. Related Products of 13325-10-5 And the article was included in Bioorganic Chemistry in 2020. The article conveys some information:
In this work, three series of ω-3 polyunsaturated fatty acid-alkanolamine derivatives (PUFA-AAs) were synthesized, characterized and their anti-inflammatory activity in vivo was evaluated. Three compounds exhibited marked anti-inflammatory activity in LPS-stimulated RAW 264.7 cells. The most promising compound cis-7,10,13,16,19-docosapentaenoic acid 2-hydroxyethyl amide (I) dose-dependently suppressed the cytokines with IC50 values in the low micromolar range. Further, I exhibited potential in vitro Nur77-binding affinity (Kd = 6.99 x 10-6 M) which is consistent with the result of docking studies. Next, the anti-inflammatory mechanism of I was found to be through NF-κB signal pathway in a Nur77-dependent manner. Moreover, we also observed I significantly inhibited LPS-induced expression of cytokines (IL-6, TNF-α, and IL-1β) through suppressing NF-κB activation and attenuated LPS-induced inflammation in mouse acute lung injury (ALI) model. In conclusion, the study strongly suggests that the PUFA-AA derivatives can be particularly as new Nur77 mediators for further treatment in inflammatory diseases. In the part of experimental materials, we found many familiar compounds, such as 4-Aminobutan-1-ol(cas: 13325-10-5Related Products of 13325-10-5)
4-Aminobutan-1-ol(cas: 13325-10-5) is used in the synthesis of NSAIDs with anti-inflammatory properties. Also used in the synthesis of polyamine transport ligands with specificity against human cancers allowing easy access to specific cancer cells.Related Products of 13325-10-5
Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts